Market Recap — February 12, 2026
Recap of insider activity, SEC filings, and market-moving news for February 12, 2026.
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Onfolio Holdings Seeks Shareholder Approval for Reverse Stock Split, Massive Dilution from Convertible Notes, and Contradictory Forward Stock Split
Holcim to Acquire Controlling Stake in Cementos Pacasmayo for S/5.1B; Reports Strong Operational Growth
Karyopharm Discloses Substantial Doubt About Going Concern, Reports Widened Net Loss, and Faces Multiple Clinical Setbacks
Annual Report Reveals Massive Loss, Trading Suspension, and Class Action Lawsuit
Shareholders Approve Merger with Ryerson; Olympic Steel to Delist Feb 13
Mercer International Reports Devastating $497.9M Net Loss for 2025, Equity Nears Zero, Dividends Suspended, and Credit Ratings Downgraded
Mercer International Reports Massive Q4 & FY25 Losses, $238.7M Impairments Amidst Pulp Market Downturn
Jiuzi Holdings Announces $60M Private Placement at Deep Discount, Massively Diluting Shareholders
Forward Industries Reports Catastrophic $585M Net Loss Driven by Digital Asset Decline
Pluri Inc. Discloses Going Concern Doubt, Worsening Losses, and Nasdaq Delisting Risk in Q2 Report
Annual Report Details Transformational Kenvue Acquisition, Significant Dilution, and Restructuring Initiatives
Envoy Medical Finalizes Highly Dilutive $30M Offering at Deep Discount Amidst Going Concern Warning
No high-importance items captured for this date.
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
10% Owner Reports Final Transactions Ahead of TreeHouse Foods' Privatization
10% Owner Broadwood Partners Buys $3M in Recent Registered Direct Offering at Premium
New 10% Owner Acquires $2.86M Stake, Including Convertible Preferred Stock
Director Summe Buys $940K in Avantor Stock Following Recent Losses
Director Peter McMillan Buys Nearly $900K in Company Stock Near 52-Week Lows
CEO Converts $120,000 Debt to Equity, Boosting Confidence
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
CEO Mark Tarr Sells $16.7M in Company Stock
CEO Gregory N. Roberts Sells Over $7.2M in Gold.com Stock Following Option Exercise
Director Sells Over $6.1 Million in Gold.com Stock
Major 10% Owner Sells Over $3 Million in Tenaya Therapeutics Shares Amid Delisting Concerns
Director Sells $2.45M in Shares Following Option Exercise
10% Owner Sells $34K in ScanTech AI Shares Amidst Nasdaq Delisting
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Shareholders Approve Merger with Ryerson; Olympic Steel to Delist Feb 13
Mercer International Reports Massive Q4 & FY25 Losses, $238.7M Impairments Amidst Pulp Market Downturn
Alkermes Completes Acquisition of Avadel Pharmaceuticals; Shares to Delist
Quince Therapeutics Warns of Potential Bankruptcy, Seeks Reverse Merger After Drug Failure
Vyome Holdings Reports Positive Phase 2 Results for VT-1953 in Malignant Fungating Wounds, Advancing to Phase 3
Nektar Therapeutics Finalizes $432M Public Offering at Deep Discount, Upsizing Prior Plan
Confluent Stockholders Approve Merger Agreement with IBM
PTC Therapeutics Withdraws Translarna NDA for Duchenne Muscular Dystrophy Following Negative FDA Feedback
Helio Corp Receives Default Notices on $250,000 in Promissory Notes, Faces Legal Action
Churchill Capital Corp X Shareholders Approve Infleqtion Merger with Strong Support and Low Redemptions
No notable 8-Ks or news items on this date.
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Owner Files Intent to Sell $13.9M in MACOM Technology Stock Amidst Ongoing Distribution
Senior Officer Files Intent to Sell Over $7 Million in Company Stock
Vice Chairman Michael McDonald Files Intent to Sell $500K in Shares
Institutional Investor Files Intent to Sell $9.38M in Hinge Health Shares
Officer and Director Michael Hsing Files Intent to Sell $38.67M in Shares
Director Benjamin Jeffrey D Files Intent to Sell $12.8 Million in Gold.com Stock
Major Shareholder Files Intent to Sell $122K in CytoMed Therapeutics Shares
CEO-affiliated entity files intent to sell $93.8M in BioNTech shares
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.